Business Wire

Rare Earth Metals Supply: The Next Microchip Crisis?

Share

With the heightened scrutiny of automotive contributions to climate change, automakers’ full attention is focused on electric vehicles (EVs). The electrification of transportation will help reduce reliance on fossil fuels, eliminate tailpipe emissions and help mitigate climate change. EVs, however, have a challenge: rare earth metals in their motors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211201005051/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Tula’s DMD™ Dynamic Motor Drive paired with synchronous reluctance motors (pictured here) could help lower EV production costs. (Photo: Business Wire)

Rare earth metals are not rare in nature, but rarely are they concentrated in amounts that make extraction and processing economically feasible. Demand for rare earth metals is increasing in conjunction with the transition to an electrified future. The anticipated supply-demand imbalance, supply-chain management issues and escalating costs are causing automakers to look for other options.

Tula Technology, Inc., a leader in propulsion efficiency, recently authored a whitepaper titled “Rare Earth Materials and their Impact on the Future of Electric Motors,” that highlights the challenges associated with rare earth metals used in EV motors and offers practical alternatives.

Tula’s Dynamic Motor Drive (DMD™), a patented DMD pulse density strategy, avoids rare earth metals in EV motors by deploying synchronous reluctance motors (SynRMs), which typically do not utilize rare earth metals. The unique control algorithms implemented through DMD improve the efficiency of SynRMs, positioning them as a viable alternative to the permanent magnet motors used in the vast majority of EVs today.

“The limited supply of rare earths, coupled with growth in demand, has resulted in price increases that are likely to continue. Beyond pricing, rare earth dependence is increasing supply chain risk, and it could easily become the next microchip crisis for the automotive industry,” said R. Scott Bailey, president and CEO of Tula. “EV manufacturers can implement an economical solution while avoiding the challenges of rare earth metals by combining synchronous reluctance motors with DMD. Our solution could lead to broader consumer adoption of EVs by lowering costs.”

DMD provides the greatest benefit for off-grid applications like EVs where battery capacity or range are concerns. The benefits of DMD also can be substantial wherever motors and generators are used, such as home appliances, industrial motors or wind power generators.

Advancing the conversation and awareness around EV technologies, Tula engineers recently presented “Optimizing Electric Motor Controls with Dynamic Motor Drive” at the 2021 Aachen Colloquium on Sustainable Mobility, an annual conference held in Aachen, Germany, as well as the Aachen China Colloquium. Both conferences attract automotive experts and researchers from around the world to exchange ideas on future mobility.

For more information on Dynamic Motor Drive, visit tulatech.com/dmd.

About Tula Technology, Inc.
Silicon Valley-based Tula Technology provides innovative award-winning software controls to optimize propulsion efficiency and emissions across the mobility spectrum, including gasoline-powered, diesel, alternative fuel, hybrid, and electric vehicles. Tula’s culture of innovation has resulted in breakthrough technologies and a robust global patent portfolio of more than 380 patents issued and pending. Tula Technology is a privately held company backed by Sequoia Capital, Sigma Partners, Khosla Ventures, GM Ventures, BorgWarner and Franklin Templeton. More information is available at www.tulatech.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tula Technology, Inc.
Ram Subramanian
Principal Marketing Strategist
ram@tulatech.com

Media: Financial Profiles
Debbie Douglas, SVP
ddouglas@finprofiles.com
949-375-3436

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release

Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i

Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release

Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct

Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release

Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we

Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release

AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by

illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release

illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye